Genocea Biosciences reported $3.6M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agenus AGEN:US USD 18.1M 809K
Baxter International BAX:US USD 782M 35M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Cytokinetics CYTK:US USD 48.22M 5.51M
Cytori Therapeutics CYTX:US USD 2.22M 67K
Genocea Biosciences GNCA:US USD 3.6M 473K
Glaxosmithkline GSK:US GBP 1.97B 13M
Infinity Pharmaceuticals INFI:US USD 3.5M 6K
Merk MRK:US USD 2.47B 13M
Mirati Therapeutics MRTX:US USD 60.8M 6.57M
Moderna Inc MRNA:US USD 278M 67M
Novavax NVAX:US USD 122.88M 14.72M
Pfizer PFE:US USD 3.54B 345M
Prothena PRTA:US USD 11.99M 963K